Screener
Viridian Therapeutics, Inc. VRDN Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $2.03B.
The source filing: Viridian Therapeutics, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 7:31 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001590750-26-000018
FAQ
- What is Viridian Therapeutics, Inc.'s market capitalization?
- Viridian Therapeutics, Inc. (VRDN) reported market capitalization of $2.03B in Q2 2026.
- How has Viridian Therapeutics, Inc.'s market capitalization changed year-over-year?
- Viridian Therapeutics, Inc.'s market capitalization increased by 69.6% year-over-year, from $1.2B to $2.03B.
- What is the long-term trend for Viridian Therapeutics, Inc.'s market capitalization?
- Over 5 years (2020 to 2025), Viridian Therapeutics, Inc.'s market capitalization has grown at a 95.4% compound annual growth rate (CAGR), from $104.23M to $2.97B.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.
Ask your AI about Viridian Therapeutics, Inc.'s market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude